Skeletal Targeted Radiotherapy (STR) is designed to be used in combination with high-dose chemotherapy producing a direct therapeutic effect on the tumor sites in the bone plus a general bone-marrow effect to destroy myeloma cells in the bone marrow.
Emerging Therapies for Multiple Myeloma
Patient Booklet (PDF)
Healthcare Professional Booklet (PDF)
STR plus Melphalan to Melphalan alone, with Stem Cell Transplant in Multiple Myeloma is enrolling patients.